BRIAN BONOMO: Open Payments
NPI 1124012596 · LECANTO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147,781 in 262 payments from 16 companies in 2025. Trend: 2023 $121,597 · 2024 $161,526 · 2025 $147,781
Speaker / faculty: $100,510Travel & lodging: $18,628Honoraria: $12,925Speaker / faculty: $8,851Food & beverage: $6,140Consulting: $650
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 71 | $44,472 |
| Janssen Biotech, Inc. | 31 | $36,470 |
| Regeneron Healthcare Solutions, Inc. | 40 | $24,215 |
| Organon LLC | 40 | $17,695 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 27 | $12,759 |
| GENZYME CORPORATION | 11 | $9,945 |
| E.R. Squibb & Sons, L.L.C. | 6 | $1,384 |
| Amgen Inc. | 8 | $233 |
| Lilly USA, LLC | 6 | $196 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
Products named: Bimzelx, TREMFYA, DUPIXENT, VTAMA, ILUMYA, Sotyktu, EBGLYSS, COSENTYX.
Industry payments across FL — which companies pay providers there.
